Predicting Urinary Tract Infections With Interval Likelihood Ratios.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 2021
Historique:
accepted: 03 09 2020
pubmed: 6 12 2020
medline: 11 5 2021
entrez: 5 12 2020
Statut: ppublish

Résumé

Protocols for diagnosing urinary tract infection (UTI) often use arbitrary cutoff values of urinalysis components to guide management. Interval likelihood ratios (ILRs) of urinalysis results may improve the test's precision in predicting UTIs. We calculated the ILR of urinalysis components to estimate the posttest probabilities of UTIs in young children. Review of 2144 visits to the pediatric emergency department of an urban academic hospital from December 2011 to December 2019. Inclusion criteria were age <2 years and having a urinalysis and urine culture sent. ILR boundaries for hemoglobin, protein, and leukocyte esterase were "negative," "trace," "1+," "2+" and "3+." Nitrite was positive or negative. Red blood cells and white blood cells (WBCs) were 0 to 5, 5 to 10, 10 to 20, 20 to 50, 50 to 100, and 100 to 250. Bacteria counts ranged from negative to "loaded." ILRs for each component were calculated and posttest probabilities for UTI were estimated. The UTI prevalence was 9.2%, with the most common pathogen being The probability of UTI in young children significantly increases with 3+ leukocyte esterase, positive nitrite results, 20 to 50 or higher WBCs, and/or many or greater bacteria on urinalysis. The probability of UTI only marginally increases with trace or 1+ leukocyte esterase or 5 to 20 WBCs. Our findings can be used to more accurately predict the probability of true UTI in children.

Sections du résumé

BACKGROUND
Protocols for diagnosing urinary tract infection (UTI) often use arbitrary cutoff values of urinalysis components to guide management. Interval likelihood ratios (ILRs) of urinalysis results may improve the test's precision in predicting UTIs. We calculated the ILR of urinalysis components to estimate the posttest probabilities of UTIs in young children.
METHODS
Review of 2144 visits to the pediatric emergency department of an urban academic hospital from December 2011 to December 2019. Inclusion criteria were age <2 years and having a urinalysis and urine culture sent. ILR boundaries for hemoglobin, protein, and leukocyte esterase were "negative," "trace," "1+," "2+" and "3+." Nitrite was positive or negative. Red blood cells and white blood cells (WBCs) were 0 to 5, 5 to 10, 10 to 20, 20 to 50, 50 to 100, and 100 to 250. Bacteria counts ranged from negative to "loaded." ILRs for each component were calculated and posttest probabilities for UTI were estimated.
RESULTS
The UTI prevalence was 9.2%, with the most common pathogen being
CONCLUSIONS
The probability of UTI in young children significantly increases with 3+ leukocyte esterase, positive nitrite results, 20 to 50 or higher WBCs, and/or many or greater bacteria on urinalysis. The probability of UTI only marginally increases with trace or 1+ leukocyte esterase or 5 to 20 WBCs. Our findings can be used to more accurately predict the probability of true UTI in children.

Identifiants

pubmed: 33277351
pii: peds.2020-015008
doi: 10.1542/peds.2020-015008
pii:
doi:

Substances chimiques

Nitrites 0
leukocyte esterase EC 3.1.-
Carboxylic Ester Hydrolases EC 3.1.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Tian Liang (T)

The State University of New York Downstate Medical Center, Brooklyn, New York; and tianzliang@gmail.com.
New York City Health and Hospitals/Kings County, Brooklyn, New York.

Silvia Schibeci Oraa (S)

The State University of New York Downstate Medical Center, Brooklyn, New York; and.
New York City Health and Hospitals/Kings County, Brooklyn, New York.

Naomi Rebollo Rodríguez (N)

The State University of New York Downstate Medical Center, Brooklyn, New York; and.
New York City Health and Hospitals/Kings County, Brooklyn, New York.

Tanvi Bagade (T)

The State University of New York Downstate Medical Center, Brooklyn, New York; and.
New York City Health and Hospitals/Kings County, Brooklyn, New York.

Jennifer Chao (J)

The State University of New York Downstate Medical Center, Brooklyn, New York; and.
New York City Health and Hospitals/Kings County, Brooklyn, New York.

Richard Sinert (R)

The State University of New York Downstate Medical Center, Brooklyn, New York; and.
New York City Health and Hospitals/Kings County, Brooklyn, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH